Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0274 | ||||
| Gene Name | SLC30A5 | ||||
| Protein Name | Zinc transporter 5 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
Modelled DT Structure Method: multi-sequence alignment based machine learning Detail: Structure Info |
||||
| Synonyms | SLC30A5; Solute carrier family 30 member 5; ZNT5; ZNTL1; ZTL1; ZnT-5; ZnT-like transporter 1; hZTL1 | ||||
| DT Family | Cation Diffusion Facilitator (CDF) Family ; | ||||
| Tissue Specificity | Ubiquitously expressed. Highly expressed inpancreas, liver and kidney. Expressed abundantly in insulin-containing beta cells, undetectable in other endocrine cell typesincluding glucagon-secreting alpha cells and most acinar cells. | ||||
| Function | This transporter is a zinc transporter. May be a transporter of zinc into beta cells in order to form insulin crystals. Partly regulates cellular zinc homeostasis. Required with ZNT7 for the activation of zinc-requiring enzymes, alkaline phosphatases (ALPs). Transports zinc into the lumens of the Golgi apparatus and vesicular compartments where ALPs locate, thus, converting apoALPs to holoALPs. | ||||
| Endogenous Substrate(s) | Zn2+ | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(α) Microbiota Influence of This DT |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(γ) Transcriptional Regulation of This DT |
|||||
|
(δ) Epigenetic Regulation of This DT |
|||||
|
General Variability Data of This DT (VARIDT 1.0) |
|||||
|
(β) Disease-specific Protein Abundances of This DT |
|||||
|
(γ) Species- and Tissue-specific DT Abundances |
|||||
| Molecular Transporting Profile of This DT | |||||
|
Full List of Drug(s) Transported by This DT |
|||||
|
Withdrawn, Discontinued or Preclinical Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
|
Zinc salts
|
Preclinical | Drug Info | Arthritis | FA5Z | [1] |
| References | |||||
| 1 | Altered expression of two zinc transporters, SLC30A5 and SLC30A6, underlies a mammary gland disorder of reduced zinc secretion into milk. Genes Nutr. 2015 Sep;10(5):487. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.